These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 36161306)
1. A Placebo-Controlled Randomized Trial of Vigabatrin in the Management of Acute Alcohol Withdrawal. Williams J; Collins L; Norman A; O'Neill H; Lloyd-Jones M; Ogden E; Bonomo Y; Pastor A Alcohol Alcohol; 2023 Jan; 58(1):40-45. PubMed ID: 36161306 [TBL] [Abstract][Full Text] [Related]
2. Baclofen during alcohol detoxification reduces the need for additional diazepam: a randomized placebo-controlled trial. Crunelle CL; Jegham S; Vanderbruggen N; Matthys F Alcohol Alcohol; 2023 Sep; 58(5):565-569. PubMed ID: 37526038 [TBL] [Abstract][Full Text] [Related]
3. A double-blind randomised crossover trial of low-dose flumazenil for benzodiazepine withdrawal: A proof of concept. MacDonald T; Gallo AT; Basso-Hulse G; Bennett KS; Hulse GK Drug Alcohol Depend; 2022 Jul; 236():109501. PubMed ID: 35644071 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of pregabalin in the treatment of alcohol withdrawal syndrome: a randomized placebo-controlled trial. Förg A; Hein J; Volkmar K; Winter M; Richter C; Heinz A; Müller CA Alcohol Alcohol; 2012; 47(2):149-55. PubMed ID: 22215002 [TBL] [Abstract][Full Text] [Related]
6. Effect of intranasal oxytocin on alcohol withdrawal syndrome: A randomized placebo-controlled double-blind clinical trial. Melby K; Gråwe RW; Aamo TO; Salvesen Ø; Spigset O Drug Alcohol Depend; 2019 Apr; 197():95-101. PubMed ID: 30784955 [TBL] [Abstract][Full Text] [Related]
7. Baclofen for alcohol withdrawal. Liu J; Wang LN Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31689723 [TBL] [Abstract][Full Text] [Related]
8. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
9. Effect of early and focused benzodiazepine therapy on length of stay in severe alcohol withdrawal syndrome. Lee JA; Duby JJ; Cocanour CS Clin Toxicol (Phila); 2019 Jul; 57(7):624-627. PubMed ID: 30729859 [No Abstract] [Full Text] [Related]
10. Lorazepam Versus Diazepam in the Management of Emergency Department Patients With Alcohol Withdrawal. Scheuermeyer FX; Miles I; Lane DJ; Grunau B; Grafstein E; Sljivic I; Duley S; Yan A; Chiu I; Kestler A; Barbic D; Moe J; Slaunwhite A; Nolan S; Ti L; Innes G Ann Emerg Med; 2020 Dec; 76(6):774-781. PubMed ID: 32736932 [TBL] [Abstract][Full Text] [Related]
11. Outcomes of Minnesota Detoxification Scale (MINDS) Assessment With High-Dose Front Loading Diazepam Treatment for Alcohol Withdrawal in Hospitalized Patients. Patel L; Beddow D; Kirven J; Smith CS; Hanovich S; Holaday K; Agboto V; St Hill CA Am J Med Sci; 2022 Jan; 363(1):42-47. PubMed ID: 34666063 [TBL] [Abstract][Full Text] [Related]
12. Symptom-triggered therapy for assessment and management of alcohol withdrawal syndrome in the emergency department short-stay clinical decision unit. Ismail MF; Doherty K; Bradshaw P; O'Sullivan I; Cassidy EM Emerg Med J; 2019 Jan; 36(1):18-21. PubMed ID: 30282630 [TBL] [Abstract][Full Text] [Related]
13. Randomized, double-blind, placebo-controlled trial of vigabatrin for the treatment of cocaine dependence in Mexican parolees. Brodie JD; Case BG; Figueroa E; Dewey SL; Robinson JA; Wanderling JA; Laska EM Am J Psychiatry; 2009 Nov; 166(11):1269-77. PubMed ID: 19651710 [TBL] [Abstract][Full Text] [Related]
14. Double-blind study of alprazolam, diazepam, clonidine, and placebo in the alcohol withdrawal syndrome: preliminary findings. Adinoff B Alcohol Clin Exp Res; 1994 Aug; 18(4):873-8. PubMed ID: 7978098 [TBL] [Abstract][Full Text] [Related]
15. Management of benzodiazepine-resistant alcohol withdrawal across a healthcare system: Benzodiazepine dose-escalation with or without propofol. Wong A; Benedict NJ; Lohr BR; Pizon AF; Kane-Gill SL Drug Alcohol Depend; 2015 Sep; 154():296-9. PubMed ID: 26205315 [TBL] [Abstract][Full Text] [Related]
16. Symptoms-triggered approach versus fixed-scheduled approach of benzodiazepines for management of alcohol withdrawal syndrome: Non-randomized controlled trial. Al-Maqbali JS; Al Alawi AM; Al-Mamari Q; Al-Huraizi A; Al-Maqrashi N Alcohol; 2023 Feb; 106():10-14. PubMed ID: 36240945 [TBL] [Abstract][Full Text] [Related]
18. A double-blind comparison of abecarnil and diazepam in the treatment of uncomplicated alcohol withdrawal. Anton RF; Kranzler HR; McEvoy JP; Moak DH; Bianca R Psychopharmacology (Berl); 1997 May; 131(2):123-9. PubMed ID: 9201799 [TBL] [Abstract][Full Text] [Related]
19. Levetiracetam for the treatment of alcohol withdrawal syndrome: a multicenter, prospective, randomized, placebo-controlled trial. Richter C; Hinzpeter A; Schmidt F; Kienast T; Preuss UW; Plenge T; Heinz A; Schaefer M J Clin Psychopharmacol; 2010 Dec; 30(6):720-5. PubMed ID: 21105289 [TBL] [Abstract][Full Text] [Related]